Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 52.60
-0.75 (-1.41%)
Apr 17, 2026, 3:30 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 19.64 billion as of April 16, 2026. Its market cap has increased by 49.04% in one year.
Market Cap
19.64B
Enterprise Value
19.10B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.60
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 19.64B, an increase of 158.78%. That is a compound annual growth rate of 15.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 19.54B | 1.63% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 30.09B |
| Duality Biotherapeutics | 28.84B |
| Shanghai Bao Pharmaceuticals | 28.69B |
| TransThera Sciences (Nanjing) | 27.77B |
| Keymed Biosciences | 23.77B |
| Zai Lab | 20.72B |
| Ascletis Pharma | 18.85B |
| Nanjing Leads Biolabs | 18.54B |